Editor,
I am writing in response to a recent article by Dr. Harris, “HPV Becoming More Common,” (published April 9).
In this article, he suggests a vaccine with alarming clinical trial data. Reviewing the CDC package insert, you would find that 1 in 40 girls in the trials reported autoimmune diseases, including celiac disease, diabetes, Crohn’s isease, multiple sclerosis, psoriasis, systemic lupus erythematosus, rheumatoid arthritis and many more, within 6 months of injection.
The control group was equal in adverse reactions, but the control was given a form of aluminum, also found in the vaccine, rather than an inert placebo. Girls already exposed to HPV (which can happen in the birth canal) had a negative 44.6 percent efficacy to cancer (they got cancer, mercola.fileburst.com/PDF/References/HPV-vaccine-clinical-trials.pdf ).
The chances of getting an autoimmune disease during adolescence from the vaccine is 1,000 times greater than dying of cervical cancer in the United States.
Human papilloma virus (HPV) clears on its own in 90 percent of cases. Why would a doctor suggest a vaccine with such a high rate of harm?
“Nobody in the world who has any concern for a little girl, would ever give her this vaccine, based upon their own clinical studies.” –Robert F. Kenned, Jr., Children’s Health Defense
Heather Barnes, Noblesville
